Jiangsu Nhwa Pharmaceutical Co., LTD (002262.SZ)
CNY 24.81
(0.36%)
CNY 24.81
(0.36%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.05 Billion | 861.02 Million | 701.11 Million | 1.24 Billion | 305.97 Million | 404.52 Million |
| Net Income | 1.03 Billion | 880.38 Million | 798.02 Million | 727.1 Million | 657.07 Million | 519.16 Million |
| Depreciation & Amortization | 175.09 Million | 148.65 Million | 135.06 Million | 96.83 Million | 88.15 Million | 109.66 Million |
| Deferred income taxes | -23.2 Million | -4.01 Million | 534.32 Thousand | -10.4 Million | -8.28 Million | -1.6 Million |
| Stock-based compensation | - | - | 2.49 Million | 10.89 Million | 32.21 Million | 25.26 Million |
| Change in working capital | -178.55 Million | -160.56 Million | -251.11 Million | 408.27 Million | -472.63 Million | -268.66 Million |
| Other non-cash items | 569.02 Million | -7.45 Million | 16.12 Million | 15.63 Million | 9.44 Million | 44.35 Million |
| Investing Cash Flow | -335.63 Million | -688.9 Million | -392.52 Million | -911.94 Million | 185.12 Million | -343.89 Million |
| Investments in PPE | -373.98 Million | -327.75 Million | -206.1 Million | -268.6 Million | -160.29 Million | -170.69 Million |
| Acquisitions | 1.35 Million | 90.8 Thousand | 153.53 Thousand | 5.77 Million | -6.18 Million | -6.63 Million |
| Investment purchases | -6.45 Billion | -5.52 Billion | 344.06 Thousand | -897.6 Thousand | 290.13 Thousand | -170 Million |
| Sales/Maturities of investments | 6.49 Billion | 32.35 Million | 34.48 Million | 28.64 Million | 6.06 Million | 1.05 Million |
| Other Investing Activities | 1.00 | 5.13 Billion | -221.39 Million | -676.86 Million | 345.25 Million | -166.56 Million |
| Financing Cash Flow | -210.17 Million | -240.77 Million | -127.43 Million | -305.07 Million | -56.36 Million | 116.73 Million |
| Debt repayment | -25 Million | -48 Million | -38 Million | -38 Million | -394.79 Million | -272.02 Million |
| Dividends payments | -201.51 Million | -201.51 Million | -100.75 Million | -101.91 Million | -77.12 Million | -63.97 Million |
| Common Stock Repurchased | - | - | -460.17 Thousand | -201.56 Million | -4.75 Million | -2.15 Million |
| Common Stock Issuance | - | - | 460.17 Thousand | 201.56 Million | 4.75 Million | - |
| Other Financing Activities | -1.1 Million | 9.95 Million | 12.86 Million | -163.56 Million | 415.56 Million | 452.73 Million |
| Accounts receivables | -199.06 Million | -155.27 Million | -122.87 Million | 475.04 Million | -559.74 Million | -248.31 Million |
| Accounts payables | -33.91 Million | 126.92 Million | 77.1 Million | 53.05 Million | 128.48 Million | 59.3 Million |
| Inventory | 54.43 Million | -128.19 Million | -205.88 Million | -109.4 Million | -33.08 Million | -78.05 Million |
| Other working capital | -7703.00 | -4.01 Million | 534.32 Thousand | -10.4 Million | -8.28 Million | -190.61 Million |
| Cash at beginning of period | 1.53 Billion | 1.57 Billion | 1.39 Billion | 1.36 Billion | 926.61 Million | 749.54 Million |
| Cash at end of period | 2.15 Billion | 1.5 Billion | 1.57 Billion | 1.39 Billion | 1.36 Billion | 926.61 Million |
| Capital Expenditure | -373.98 Million | -327.75 Million | -206.1 Million | -268.6 Million | -160.29 Million | -170.69 Million |
| Effect of forex changes on cash | 414.76 Thousand | 907.94 Thousand | -1.14 Million | -380.07 Thousand | -101.32 Thousand | -298.06 Thousand |
| Net cash flow / Change in cash | 626.73 Million | -67.74 Million | 180.01 Million | 30.94 Million | 434.62 Million | 177.06 Million |
| Free Cash Flow | 676.55 Million | 533.27 Million | 495.01 Million | 979.73 Million | 145.67 Million | 233.82 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 391.18 Million | 363.63 Million | 265.28 Million | 1.03 Billion | 151.27 Million | 340.93 Million |
| Depreciation & Amortization | - | 54.87 Million | 54.87 Million | 175.09 Million | 46.24 Million | -77.55 Million |
| Deferred income taxes | - | - | - | -23.2 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | -216.88 Million | - | -178.55 Million | -144.63 Million | 159.75 Million |
| Other non-cash items | -81.88 Million | 90.18 Million | -26.25 Million | 569.02 Million | 146.59 Million | -52.33 Million |
| Investing Cash Flow | -257.56 Million | -286.25 Million | -680.24 Million | -335.63 Million | -235.38 Million | -262.52 Million |
| Investments in PPE | -69.97 Million | -145.38 Million | -64.24 Million | -373.98 Million | -148.51 Million | -74.19 Million |
| Acquisitions | 460.11 Thousand | 143.71 Thousand | - | 1.35 Million | 827.63 Thousand | 200 Thousand |
| Investment purchases | 3.22 Billion | -3.22 Billion | - | -6.45 Billion | -6.45 Billion | 3.63 Billion |
| Sales/Maturities of investments | 19.94 Million | 2.46 Billion | 6.72 Million | 6.49 Billion | 6.49 Billion | 8.77 Million |
| Other Investing Activities | -207.52 Million | 616 Million | -622.72 Million | 1.00 | -124.7 Million | -3.83 Billion |
| Financing Cash Flow | 44.09 Million | -311.73 Million | 3.23 Million | -210.17 Million | 16.38 Million | -11.02 Million |
| Debt repayment | -20.08 Million | -19.69 Million | -10 Million | -25 Million | -25 Million | -15 Million |
| Dividends payments | -713.3 Thousand | -322.42 Million | -1.28 Million | -201.51 Million | -2.86 Million | -2.07 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 63.45 Million | -9 Million | -6.76 Million | -1.1 Million | 23.93 Million | 6.05 Million |
| Accounts receivables | - | -306.6 Million | - | -199.06 Million | -199.06 Million | 168.68 Million |
| Accounts payables | - | - | - | -33.91 Million | - | - |
| Inventory | - | 89.71 Million | - | 54.43 Million | 54.43 Million | -8.93 Million |
| Other working capital | - | - | - | -7703.00 | -7702.00 | - |
| Cash at beginning of period | 1.37 Billion | 1.63 Billion | 2.15 Billion | 1.53 Billion | 2.06 Billion | 1.92 Billion |
| Cash at end of period | 1.44 Billion | 1.42 Billion | 1.63 Billion | 2.15 Billion | 2.15 Billion | 2.02 Billion |
| Capital Expenditure | -69.97 Million | -145.38 Million | -64.24 Million | -373.98 Million | -148.51 Million | -74.19 Million |
| Effect of forex changes on cash | 35.95 Thousand | 47.43 Thousand | 129.75 Thousand | 414.76 Thousand | 385.76 Thousand | 2038.39 |
| Net cash flow / Change in cash | 75.91 Million | -206.22 Million | -523.52 Million | 626.73 Million | 92.63 Million | 97.25 Million |
| Free Cash Flow | 239.32 Million | 253.56 Million | 174.77 Million | 676.55 Million | 50.96 Million | 296.61 Million |
VOLTAMP
2546
3031
5906
8478
0291